GlassScriptPhysician profile
John Russell Davis
NPI 1891775920
$50,112.07
in general payments reported to CMS, 2019-2025
24 companies · $9,504 in 2025
The $9,504 reported for 2025 was more than what 89% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,869 · 2020: $5,288 · 2021: $12K · 2022: $5,386 · 2023: $6,943 · 2024: $4,011 · 2025: $9,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,453 · Travel and Lodging: $6,441 · Food and Beverage: $5,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,452.50 |
| Travel and Lodging | $6,440.66 |
| Food and Beverage | $5,564.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $14,986.49 | 2020-2025 | Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia, Pascal |
| Intuitive Surgical, INC. | $14,980.89 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $9,680.55 | 2021-2025 | Imfinzi |
| Abbott Laboratories | $2,020.29 | 2019-2025 | Epic, Navitor, Mitraclip |
| Artivion, INC. | $1,908.67 | 2022-2025 | Amds-Ascyrus Medical, Bioglue Surgical Adhesive, Cryovalve Sg Pulmonary Human Heart Valve |
| W. L. Gore & Associates, INC. | $1,764.17 | 2019-2022 | |
| Abiomed | $833.30 | 2021-2024 | Impella |
| Atricure, INC. | $831.82 | 2021-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Zimmer Biomet Holdings, INC. | $737.90 | 2020-2023 | Sternalock |
| Boston Scientific Corporation | $425.14 | 2019-2021 | |
| Livanova USA, INC. | $353.04 | 2019 | |
| Corcym INC | $231.33 | 2022 | |
| Davol INC. | $175.86 | 2022 | |
| Angiodynamics, INC. | $173.18 | 2021 | |
| Biom'Up France Sas | $172.30 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $169.13 | 2019-2025 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Paragonix Technologies, INC. | $161.45 | 2024 | Baroguard, Lungguard, Sherpapak |
| Medtronic, INC. | $156.70 | 2023-2024 | Penditure, Resolute Onyx |
| Helios Cardio INC | $130.67 | 2023 | |
| La Jolla Pharmaceutical Company | $91.67 | 2021 | |
| Haemonetics Corporation | $44.24 | 2023 | Teg5000 Hemostasis Analyzer |
| Baxter Healthcare | $33.31 | 2019 | |
| Veryan Medical Incorporated | $32.14 | 2025 | Biomimics 3d Vascular Stent System |
| Medtronic Vascular, INC. | $17.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.